lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

Clinical Features and Predictors for Patients with Severe SARS-CoV-2 Pneumonia: A Retrospective Multicenter Cohort Study

20 Pages Posted: 31 Mar 2020

See all articles by Chao Cao

Chao Cao

Ningbo First Hospital - Department of Respiratory and Critical Medicine

Meiping Chen

Ningbo First Hospital - Department of Respiratory and Critical Medicine

Yiting Li

Ningbo First Hospital - Department of Respiratory and Critical Medicine

Lili Yu

Yangtze University - Department of Respiratory and Critical Care Medicine

Weina Huang

Ningbo First Hospital - Department of Respiratory and Critical Medicine

Guoqing Qian

Ningbo First Hospital - Department of Respiratory and Critical Medicine

Chuanbing Zhu

Yangtze University - Department of Respiratory and Critical Care Medicine

Jinguo Chu

Ningbo First Hospital - Department of Respiratory and Critical Medicine

Li He

Yangtze University - Department of Respiratory and Critical Care Medicine

Jingping Ma

Yangtze University - Department of Respiratory and Critical Medicine

Xiaomin Chen

Zhejiang University - Department of Cardiology

More...

Abstract

Background: Starting from early December 2019, cases of human infection with a novel coronavirus were identified in Wuhan, Hubei Province, China. It spreads rapidly to other cities and numerous countries. This study was performed to investigate clinical features of patients with severe SARS-CoV-2 pneumonia and identify risk factors for converting to severe cases in those who had mild to moderate diseases.

Methods: In this retrospective, multicenter cohort study, patients with mild to moderate SARS-CoV-2 pneumonia were included from Ningbo First Hospital and Jingzhou Central Hospital. Demographic data, symptoms, laboratory values, comorbidities, and clinical outcomes were collected. Data were compared between non-severe and severe patients. Logistic regression analysis was performed to assess risk factors in predicting the patients with SARS-CoV-2 pneumonia who would convert to severe cases.

Findings: 120 patients (36 from Ningbo First Hospital and 84 from Jingzhou Central Hospital) were included in this study, among which 62 were excluded and 58 were included in the final analysis. Compared with non-severe cases, severe patients with SARS-CoV-2 pneumonia had a longer: time to clinical recovery (12·9±4·4 vs 8·3±4·7; p=0·0011), duration of viral shedding (15·7±6·7 vs 11·8±5·0; p=0·0183), and hospital stay (20·7±1·2 vs 14·4±4·3; p=0·0211). Multivariate logistic regression indicated that lymphocyte count was significantly associated with the rate of converting to severe cases (odds ratio 1·28, 95%CI 1·06–1·54, per 0·1×109/L reduced; p=0·007), while using of low-to-moderate doses of systematic corticosteroids was associated with reduced likelihood of converting to a severe case (odds ratio 0·14, 95%CI 0·02–0·80; p=0·0275).

Interpretation: The low peripheral blood lymphocyte count was an independent risk factor for SARS-CoV-2 pneumonia patients converting to severe cases. This finding may help clinicians more accurately predict prognosis, and triage priorities to improve clinical outcomes.

Funding Statement: None.

Declaration of Interests: All authors declare no competing interests.

Ethics Approval Statement: Ethical approvals for this study were obtained from the Ethics Commission of Ningbo First Hospital (2020-R017) and the Ethics Commission of Jingzhou Central Hospital (2020-2-19). Written informed consent was waived due to the rapid emergence of this disease.

Keywords: SARS-CoV-2; pneumonia; lymphocyte counts; corticosteroids

Suggested Citation

Cao, Chao and Chen, Meiping and Li, Yiting and Yu, Lili and Huang, Weina and Qian, Guoqing and Zhu, Chuanbing and Chu, Jinguo and He, Li and Ma, Jingping and Chen, Xiaomin, Clinical Features and Predictors for Patients with Severe SARS-CoV-2 Pneumonia: A Retrospective Multicenter Cohort Study (3/13/2020). Available at SSRN: https://ssrn.com/abstract=3556663 or http://dx.doi.org/10.2139/ssrn.3556663

Chao Cao

Ningbo First Hospital - Department of Respiratory and Critical Medicine

China

Meiping Chen

Ningbo First Hospital - Department of Respiratory and Critical Medicine

China

Yiting Li

Ningbo First Hospital - Department of Respiratory and Critical Medicine

China

Lili Yu

Yangtze University - Department of Respiratory and Critical Care Medicine

Jingzhou
China

Weina Huang

Ningbo First Hospital - Department of Respiratory and Critical Medicine

China

Guoqing Qian

Ningbo First Hospital - Department of Respiratory and Critical Medicine

China

Chuanbing Zhu

Yangtze University - Department of Respiratory and Critical Care Medicine

Jingzhou
China

Jinguo Chu

Ningbo First Hospital - Department of Respiratory and Critical Medicine

China

Li He

Yangtze University - Department of Respiratory and Critical Care Medicine

Jingzhou
China

Jingping Ma

Yangtze University - Department of Respiratory and Critical Medicine ( email )

China

Xiaomin Chen (Contact Author)

Zhejiang University - Department of Cardiology ( email )

China

Click here to go to TheLancet.com

Paper statistics

Abstract Views
553
Downloads
68